Compare BioHarvest Sciences (CNVCF) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

BioHarvest Sciences (CNVCF)

Price

$5.71

Change

+1.33%

Market Cap

$57.1M

Sector

Biotech

Biotech Sector Peers

All Biotech cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
JAZZJazz Pharmaceuticals$178.55-1.66%$10.99B
INNPFInnocanPharma$5.070.00%$354.9M
ZYNEZynerba Pharmaceuticals$1.30+3.17%$33.8M
XXII22nd Century Group$3.88+1.97%$2.0M
OVATFOvation Science$0.020.00%$623.3K

Top Matchups by Market Cap

Companies closest to BioHarvest Sciences in market capitalization — the most meaningful head-to-head comparisons.

AFCGREIT

AFC Gamma (Advanced Flower Capital)

MCap: $61.9M

$2.63+0.38%
Compare
GRWGAncillary

GrowGeneration

MCap: $63.4M

$1.06-2.75%
Compare
FORAAncillary

Forian Inc

MCap: $63.7M

$2.05-0.97%
Compare
NVACFLP

Nova Cannabis

MCap: $50.6M

$1.26-0.47%
Compare
AAWHMSO

Ascend Wellness Holdings

MCap: $47.0M

$0.49-0.89%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Biotech sector. Compare across different business models and market segments.

SMGAncillary

Scotts Miracle-Gro

MCap: $3.54B

$60.96+0.96%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
TPBAncillary

Turning Point Brands

MCap: $1.73B

$90.62+0.69%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.48B

$52.66-2.34%
Compare

Comparing CNVCF in the Cannabis Market

BioHarvest Sciences (CNVCF) is a Biotech-sector cannabis company trading at $5.71 per share with a market capitalization of $57.1M. Among its Biotech peers, CNVCF ranks #3 by market cap, with trailing twelve-month revenue of $0 and a gross margin of 0.0%. The stock has moved +1.33% in the current session, trading on the OTC exchange.

When comparing CNVCF against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (N/A), revenue growth (0.00% YoY), and balance sheet strength (cash of $0 vs. debt of $0). The comparison tables above allow you to evaluate BioHarvest Sciences relative to 5 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does CNVCF compare to other Biotech stocks?+
BioHarvest Sciences has a market cap of $57.1M, placing it among 6 companies in the Biotech sector. Its price-to-sales ratio is N/A and its gross margin is 0.0%. Use the table above to compare these metrics against every Biotech peer.
What is CNVCF's biggest competitor?+
By market capitalization, the closest comparable company is AFC Gamma (Advanced Flower Capital) (AFCG) with a market cap of $61.9M. Click the compare link to view a full head-to-head analysis.
Is CNVCF overvalued compared to its peers?+
BioHarvest Sciences trades at a P/S ratio of N/A. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than CNVCF?+
BioHarvest Sciences has a gross margin of 0.0%. Among its Biotech peers, 1 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare CNVCF to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Biotech. You can click any company to see a full side-by-side comparison with CNVCF covering price, valuation, financials, and growth metrics.

Related Pages

CNVCF Stock OverviewCNVCF FinancialsCNVCF NewsCNVCF Investment AnalysisBiotech Sector StocksAll Cannabis Stocks

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.